News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,063 Results
Type
Article (41672)
Company Profile (272)
Press Release (683109)
Multimedia
Podcasts (81)
Webinars (18)
Section
Business (205468)
Career Advice (2041)
Deals (35586)
Drug Delivery (111)
Drug Development (81533)
Employer Resources (173)
FDA (16454)
Job Trends (15010)
News (347492)
Policy (32832)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2615)
Academic (1)
Accelerated approval (33)
Adcomms (24)
Allergies (142)
Alliances (49873)
ALS (171)
Alzheimer's disease (1673)
Antibody-drug conjugate (ADC) (313)
Approvals (16727)
Artificial intelligence (518)
Autoimmune disease (159)
Automation (41)
Bankruptcy (363)
Best Places to Work (11664)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (178)
Bladder cancer (158)
Brain cancer (57)
Breast cancer (640)
Cancer (4833)
Cardiovascular disease (403)
Career advice (1723)
Career pathing (37)
CAR-T (284)
CDC (44)
Celiac Disease (2)
Cell therapy (748)
Cervical cancer (36)
Clinical research (69683)
Collaboration (1715)
Company closure (4)
Compensation (1167)
Complete response letters (56)
COVID-19 (2728)
CRISPR (94)
C-suite (858)
Cystic fibrosis (143)
Data (6264)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (503)
Diagnostics (6727)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (255)
Drug pricing (185)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90315)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117735)
Executive appointments (981)
FDA (19593)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1486)
Gene editing (200)
Generative AI (43)
Gene therapy (598)
GLP-1 (966)
Government (4690)
Grass and pollen (6)
Guidances (384)
Healthcare (18910)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (254)
Immuno-oncology (57)
Indications (115)
Infectious disease (3005)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (254)
Interviews (318)
IPO (16659)
IRA (50)
Job creations (3679)
Job search strategy (1441)
JPM (57)
Kidney cancer (16)
Labor market (87)
Layoffs (550)
Leadership (34)
Legal (7969)
Liver cancer (92)
Longevity (14)
Lung cancer (654)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (803)
MASH (165)
Medical device (13807)
Medtech (13861)
Mergers & acquisitions (20003)
Metabolic disorders (1273)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (321)
Neuropsychiatric disorders (88)
Neuroscience (2917)
Neurotech (1)
NextGen: Class of 2026 (6539)
Non-profit (4544)
Now hiring (67)
Obesity (597)
Opinion (261)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (228)
Parkinson's disease (283)
Partnered (33)
Patents (505)
Patient recruitment (496)
Peanut (56)
People (59202)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21749)
Phase 2 (30660)
Phase 3 (22835)
Pipeline (5386)
Policy (285)
Postmarket research (2569)
Preclinical (9230)
Press Release (68)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (282)
Rare diseases (841)
Real estate (6015)
Recruiting (70)
Regulatory (24588)
Reports (53)
Research institute (2431)
Resumes & cover letters (354)
Rett syndrome (27)
RNA editing (16)
RSV (79)
Schizophrenia (148)
Series A (243)
Series B (191)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3639)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (85)
The Weekly (54)
Vaccines (1018)
Venture capital (89)
Weight loss (381)
Women's health (92)
Worklife (18)
Date
Today (158)
Last 7 days (582)
Last 30 days (2249)
Last 365 days (30000)
2026 (3749)
2025 (30221)
2024 (35260)
2023 (40139)
2022 (51245)
2021 (55810)
2020 (54207)
2019 (46687)
2018 (35176)
2017 (32278)
2016 (31673)
2015 (37787)
2014 (31481)
2013 (26557)
2012 (28755)
2011 (29438)
2010 (27552)
Location
Africa (741)
Alabama (84)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39471)
Australia (6450)
California (11357)
Canada (3303)
China (1103)
Colorado (479)
Connecticut (480)
Delaware (340)
Europe (85088)
Florida (1705)
Georgia (359)
Hawaii (3)
Idaho (61)
Illinois (866)
India (67)
Indiana (524)
Iowa (22)
Japan (433)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1388)
Massachusetts (8132)
Michigan (326)
Minnesota (630)
Mississippi (6)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3019)
New Mexico (28)
New York (2993)
North Carolina (1462)
North Dakota (8)
Northern California (5550)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2291)
Puerto Rico (24)
Rhode Island (48)
South America (1117)
South Carolina (66)
South Dakota (1)
Southern California (4428)
Tennessee (178)
Texas (1753)
United States (40264)
Utah (337)
Vermont (1)
Virginia (267)
Washington D.C. (81)
Washington State (925)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
725,063 Results for "clearside biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
August 27, 2025
·
7 min read
Press Releases
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
July 23, 2025
·
4 min read
Press Releases
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
June 18, 2025
·
6 min read
Press Releases
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
May 21, 2025
·
1 min read
Press Releases
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
May 2, 2025
·
1 min read
BioMidwest
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting
Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.
June 12, 2024
·
7 min read
Press Releases
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
·
8 min read
Press Releases
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
May 9, 2025
·
1 min read
Press Releases
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
July 18, 2025
·
10 min read
Press Releases
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
May 12, 2025
·
8 min read
1 of 72,507
Next
